Phase 1 Study of Sunitinib (SU011248) in Combination With Pemetrexed in Patients With Advanced Solid Malignancies in Japan.
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Sunitinib (Primary) ; Pemetrexed
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Pfizer
- 17 Dec 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2009 Interim results were reported at the 13th World Conference on Lung Cancer.